NDLI: Efficacy and tolerability of rifaximin in combination with lactulose in end-stage liver disease patients with MELD greater than 20: a single center experience.

Please wait, while we are loading the content...

Year: 2017 Volume: 49

Year: 2016 Volume: 48

Year: 2015 Volume: 47

Year: 2014 Volume: 46

Year: 2014 Volume: 46 Issue: 10

The effect of psychological support for the relatives of intensive care unit patients on cadaveric organ donation rate.

Satisfaction with the organ donation process of brain dead donors' families in Korea.

Adenosine receptor expression in the development of renal fibrosis following ischemic injury.

RAndomized Comparison of raDIal vs. femorAL Access for Routine Catheterization of Heart Transplant Patients (RADIAL-heart transplant study).

Contraception in women after organ transplantation.

Return to work after organ transplantation: a cross-sectional study on working ability evaluation and employment status.

Hepatocellular protein profiles after hepatic ischemia/reperfusion injury with or without octreotide preconditioning in a rabbit model.

Cost-effectiveness of kidney transplantation from DCD in Italy.

Brain death is associated with endoplasmic reticulum stress and apoptosis in rat liver.

Triptolide attenuates acute small-for-size liver graft injury in rats by inhibition of Toll-like receptor 4.

Low-flow hypothermic crystalloid perfusion is superior to cold storage during prolonged heart preservation.

Heart donation after cardiac death: preliminary study on an isolated, perfused swine heart after 20 minutes of normothermic ischemia.

Dopamine treatment of brain-dead Fisher rats improves renal histology but not early renal function in Lewis recipients after prolonged static cold storage.

Can ischemia-modified albumin be used as an objective biomarker for renal ischemic damage? An experimental study with Wistar albino rats.

Pretransplant biopsy in expanded criteria donors: do we really need it?

Kidneys from standard-criteria donors with different severities of terminal acute kidney injury.

Low incidence of coronary angiography in the evaluation process of the potential heart donor.

Performance of the ImmuKnow assay in differentiating infection and acute rejection after kidney transplantation: a meta-analysis.

Contrast-enhanced ultrasonography in the early period after kidney transplantation predicts long-term allograft function.

Serum microRNAs as new diagnostic biomarkers for pre- and post-kidney transplantation.

Can stroke volume variation be an alternative to central venous pressure in patients undergoing kidney transplantation?

C4d immunoreactivity of intraoperative zero-hour biopsy in renal allograft.

Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.

A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids?

Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results.

Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors.

Comparison of cadaveric kidney transplantation from in-center and external center donors.

Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction.

Alemtuzumab induction and antibody-mediated rejection in kidney transplantation.

Safety of kidney transplantation using anti-HBc-positive donors.

Dual kidney transplantation involving organs from expanded criteria donors: a review of our series and an update on current indications.

Outcomes in obese kidney transplant recipients.

Outcomes of paired-exchange live-donor kidney transplantation: a single-center experience.

HLA-identical sibling renal transplantation: influence of donor and recipient gender mismatch on long-term outcomes.

Quality of life and psychology after living-related kidney transplantation from donors and recipients in China.

A novel and personalized rehabilitation program for obese kidney transplant recipients.

Negative impact of underlying non-insulin-dependent diabetes mellitus nephropathy on long-term allograft survival in kidney transplantation: a 10-year analysis from a single center.

N-terminal pro-B-type natriuretic peptide is inversely related to bone mineral density in renal transplant recipients.

Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction.

Surgical site and early urinary tract infections in 1000 kidney transplants with antimicrobial perioperative prophylaxis.

Impact of ureteral stenting on urological complications after kidney transplantation surgery: a single-center experience.

Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infection after kidney transplantation.

Bladder cancer in renal allograft recipients: risk factors and outcomes.

Perioperative predictors for refractory hyperglycemia during the neohepatic phase of liver transplantation.

Efficacy and tolerability of rifaximin in combination with lactulose in end-stage liver disease patients with MELD greater than 20: a single center experience.

Accuracy of urine collection methods compared to measured GFR in adults with liver disease.

Balloon aortic valvuloplasty as a bridge to liver transplantation in patients with severe aortic stenosis: a case series.

Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.

Model for End-Stage Liver Disease (MELD) score does not predict outcomes of hepatitis B-induced acute-on-chronic liver failure in transplant recipients.

Kinetics of interleukin-6, procalcitonin, and C-reactive protein after pediatric liver transplantation.

CD152 and PD-1 down-regulation on CD8 T cells is associated with human acute liver allograft rejection.

Sleep disturbances and quality of life in patients after living donor liver transplantation.

Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.

Systematic computer tomographic scans 7 days after liver transplantation surgery can lower rates of repeat-transplantation due to arterial complications.

Risk factors of cytomegalovirus infection after pediatric liver transplantation.

Correlation between risk of hepatitis B virus recurrence and tissue expression of covalently closed circular DNA in living donor liver transplant recipients treated with high-dose hepatitis B immunoglobulin.

Prophylactic use of liposomal amphotericin B in preventing fungal infections early after liver transplantation: a retrospective, single-center study.

Risk factors for mortality in liver transplant recipients with ESKAPE infection.

Incidence and risk factors of deep vein thrombosis after liver transplantation.

Anti-thymocyte gamma-globulin may prevent antibody production after heart transplantation.

Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.

Endomyocardial biopsy technique for orthotopic heart transplantation and cardiac stem-cell harvesting.

Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.

Increased incidence of transfusion-related acute lung injury during orthotopic liver transplantation: a short report.

Acute kidney injury after ex vivo lung perfusion (EVLP).

Clinical usefulness of oral immunoglobulins in lung transplant recipients with norovirus gastroenteritis: a case series.

Risk factors for hepatotoxicity in solid organ transplants recipients being treated for tuberculosis.

Glomerular diseases associated with chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: case reports.

Short-term pharmacokinetic study of mycophenolate mofetil in neonatal swine.

Evaluating the impact of gastrointestinal episodes on the health-related quality of life of solid organ transplant recipients: sensitivity to change of the SIGIT-QoL questionnaire: Mypaciente-2 study.

Local cytotoxic T-lymphocyte-associated antigen-4 immunoglobulin inhibition of rejection response is dependent on indoleamine 2,3-dioxygenase activities in the allograft.

Infusion of dendritic cells carrying donor lymphocytes treated with 8-methoxypsoralen and ultraviolet A light induces CD19+ IL-10+ regulatory B cells and promotes skin allograft survival.

Features and ethical considerations associated with living kidney and liver transplantations in South Korea.

Year: 2014 Volume: 46 Issue: 9

Year: 2014 Volume: 46 Issue: 7

Year: 2014 Volume: 46 Issue: 6

Year: 2014 Volume: 46 Issue: 5

Year: 2014 Volume: 46 Issue: 4

Year: 2014 Volume: 46 Issue: 3

Year: 2014 Volume: 46 Issue: 2

Year: 2014 Volume: 46 Issue: 1

Year: 2013 Volume: 45

Year: 2012 Volume: 44

Year: 2011 Volume: 43

Year: 2010 Volume: 42

Year: 2009 Volume: 41

Efficacy and tolerability of rifaximin in combination with lactulose in end-stage liver disease patients with MELD greater than 20: a single center experience.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Mantry, P. S. Mehta, A. Graydon, R.
Description	Author Affiliation: Mantry PS ( Hepatobiliary Tumor Program, The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas. Electronic address: parvezmantry@mhd.com.); Mehta A ( Hepatobiliary Tumor Program, The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas.); Graydon R ( Hepatobiliary Tumor Program, The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas.)
Abstract	BACKGROUND: Rifaximin is a non-absorbable antibiotic which is approved for the treatment of hepatic encephalopathy (HE) in the United States. Our goal was to retrospectively assess this in patients with very advanced liver disease with our center data. METHODS: Between 2003 and 2010, we examined a total of 286 consecutive patients from our center who were on a combination of rifaximin and lactulose, who had been evaluated or listed as eligible for a liver transplant. Patients who received less than 3 months of rifaximin and lactulose were excluded. Patients who had incomplete data; specifically, a lack of MELD score upon hospital admission were excluded from this analysis. The retrospective chart review was approved by the institutional review board. RESULTS: We observed a total of 723 hospitalizations among the patients. Of the 723 hospitalizations, 218 were due to portosystemic encephalopathy (PSE), whereas 505 were due to other causes. We observed that patients with a MELD < 20 had an average of 2.5 hospitalizations per 6 month period, and that those with a MELD > 20 had an average of 1.6 hospitalizations per 6 month period for HE. At the same time, patients who had a MELD score < 20 had 3.29 hospitalizations for HE unrelated causes and those whose MELD was >20 had 3.73 hospitalizations for causes not related to HE. In this cohort 65% of all hospitalizations from HE were in patients whose MELD was < 20, and 35% of all hospitalizations were for patients with a MELD > 20. CONCLUSION: In our experience, HE related hospitalizations were lower in patients whose MELD > 20 who were on a combination of rifaximin and lactulose compared to patients with MELD < 20. In contrast, patients whose MELD > 20 had greater hospitalizations for non HE events which may be an expected result owing to the overall increased severity of their liver disease. The limitation of this study is its retrospective nature and single center experience. In conclusion, administration of rifaximin appears to significantly reduce hospitalizations from HE in patients with MELD > 20 and therefore is advocated in maintenance of remission of HE in patients with very advanced liver disease.
File Format	HTM / HTML
ISSN	00411345
Issue Number	10
Volume Number	46
e-ISSN	18732623
Journal	Transplantation Proceedings
Language	English
Publisher	Elsevier
Publisher Date	2014-12-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Transplantation__semicolon__medicine Drug Tolerance End Stage Liver Disease Drug Therapy Lactulose Pharmacology Liver Transplantation Rifamycins Drug Therapy, Combination Surgery Female Gastrointestinal Agents Humans Male Middle Aged Retrospective Studies Journal Article Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Transplantation Surgery

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in